Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 28 Jul 2026 for Adma Biologics, INC., €23k. Read the official filing
Filing timeline
BuySaleKaitlin M. Kestenberg-Messina
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kaitlin M. Kestenberg-Messina: trading record in brief
Kaitlin M. Kestenberg-Messina discloses dealings in Adma Biologics, Inc. to SEC (Form 4). Between 31 March 2024 and 24 July 2026, the trades on record add up to 27 filings.
Sales make up the whole of the open-market record (1 sale, €137k). Besides market trades, the filings include 17 share grants and 8 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 28 July 2026 came the latest disclosure, a share grant for €23k in Adma Biologics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kaitlin M. Kestenberg-Messina
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
3,177 shares@ US$8.37Common StockSEC:0001140361-26-029923:0
20,362 shares@ US$9.1113.0% of flowCommon StockSEC:0001140361-26-013206:0
10,059 shares@ US$15.390.0070% mcap12.4% of flowCommon StockSEC:0001140361-26-008905:0
4,235 shares@ US$15.390.0029% mcap5.2% of flowCommon StockSEC:0001140361-26-008905:1
2,500 shares@ US$5.000.0006% mcap1.0% of flowCommon StockSEC:0001140361-26-008905:3
1,250 shares@ US$4.310.0002% mcap0.4% of flowCommon StockSEC:0001140361-26-008905:4
2,646 shares@ US$2.830.0003% mcap0.6% of flowCommon StockSEC:0001140361-26-008905:5
1,525 shares@ US$2.350.0002% mcap0.3% of flowCommon StockSEC:0001140361-26-008905:6
2,175 shares@ US$1.550.0002% mcap0.3% of flowCommon StockSEC:0001140361-26-008905:7
10,096 shares@ US$15.630.0071% mcap12.7% of flowCommon StockSEC:0001140361-26-008905:8
91,266 shares0Common StockSEC:0001140361-26-008905:2
8,161 shares@ US$16.328.0% of flowCommon StockSEC:0001140361-26-006462:0
91,631 shares0Common StockSEC:0001140361-26-004891:0
2,500 shares@ US$8.981.5% of flowCommon StockSEC:0001140361-25-028449:0
3,027 shares@ US$17.313.5% of flowCommon StockSEC:0001140361-25-027642:0
18,920 shares@ US$19.4231.7% of flowCommon StockSEC:0001140361-25-011931:0
8,881 shares@ US$16.9113.0% of flowCommon StockSEC:0001140361-25-007923:0
1,855 shares@ US$15.442.5% of flowCommon StockSEC:0001140361-25-006385:0
77,784 shares0Common StockSEC:0001140361-25-005535:0
5,000 shares@ US$10.804.8% of flowCommon StockSEC:0001140361-25-002926:0
1,854 shares@ US$17.152.8% of flowCommon StockSEC:0001140361-25-000271:0
2,647 shares@ US$19.994.4% of flowCommon StockSEC:0001140361-24-042642:0
8,125 shares@ US$2.351.6% of flowCommon StockSEC:0001140361-24-039822:0
2,502 shares@ US$13.582.9% of flowCommon StockSEC:0001140361-24-034472:0
2,085 shares@ US$11.182.0% of flowCommon StockSEC:0001140361-24-032247:0
25 of 27 declarations
